A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12%

B Amichai1, M H Grunwald

  • 1Department of Dermatology, Sheba Medical Center, Tel. Hashomer, Israel. boazam@clalit.org.il

Insights

A new liquid soap with ammonium lactate and urea effectively treated atopic dermatitis (AD) symptoms like dryness and scaling in a 3-week study. This topical treatment improved skin condition for patients with mild to moderate AD.

Area of Science:

  • Dermatology
  • Clinical Research
  • Dermatological Therapeutics

Background:

  • Atopic dermatitis (AD) is a prevalent chronic inflammatory skin condition, frequently impacting children.
  • Xerosis (dry skin) is a particularly distressing symptom for individuals with AD.
  • Current management strategies for AD often involve topical treatments to alleviate symptoms.

Purpose of the Study:

  • To assess the therapeutic efficacy of a novel liquid soap formulation containing 12% ammonium lactate and 20% urea.
  • To evaluate the impact of this specialized soap on key clinical indicators of atopic dermatitis.
  • To compare the effectiveness of the active soap against a placebo in patients with mild to moderate AD.

Main Methods:

  • A randomized, double-blind, placebo-controlled study involving 36 participants (aged 3-40) with mild to moderate AD.
  • Participants were randomized into active treatment (2:1 ratio) and placebo groups for daily soap use over three weeks.
  • Efficacy was evaluated through clinician assessments and patient-reported outcomes, focusing on scaling, dryness, redness, and itch.

Main Results:

  • Significant improvements were observed in scaling (P < 0.0001) and skin dryness (P < 0.0001) in the active treatment group compared to placebo.
  • Investigator-rated redness also showed significant improvement (P = 0.03).
  • Patient-reported itch significantly decreased (P < 0.001) in the group using the ammonium lactate and urea soap.

Conclusions:

  • The liquid soap containing 12% ammonium lactate and 20% urea demonstrated significant efficacy in managing symptoms of atopic dermatitis.
  • The formulation proved effective in improving objective measures of skin condition and subjective patient-reported itch.
  • This specialized soap represents a potentially beneficial therapeutic option for patients with stable, mild to moderate atopic dermatitis.